Evidence suggests that regular cannabis users have different response to stress compared to non-users
Too Much of a Good Thing?
A little THC reduces stress, but higher doses have the opposite effect, research has found
The Importance of Being Earnest
Suspiciously low failure rates have earned a Washington-based cannabis testing lab a suspension
The Thin Green Line
To ensure the safety of cannabis consumers, regulators must walk the tightrope between rigor and pragmatism.
Optimization of cannabis extraction yield by controlled milling
The Fritsch PULVERISETTE 19 is utilized to finely mill cannabis plant material in preparation for SFE processes.
Pharma's Great Green Rush
A resurgence in interest from medicine makers is opening up new avenues in cannabinoid research
How unravelling the complex chemistry of the cannabis plant can lead to new medicines
Smashing the Stigma with Science
Neil Mahapatra gives the story behind a partnership with Oxford University to develop cannabinoid medicines
A View From the Biosynthetic Bridge
What are biosynthetic cannabinoids? And what do they mean for pharma?
Making Cannabis Labs Accountable
Susan Audino, Assessor and Instructor at A2LA, and Chemistry Laboratory Consultant at S.A. Audino & Associates
How software could enhance transparency in cannabis cultivation – and help speed up the legalization process
Breaking with Tradition
What does legalizing medical cannabis mean for conventional pharmaceuticals?
Treating Opioid Addiction with CBD? TBD...
Could cannabis come to the rescue in the midst of an “opioid epidemic”?
The Mother of All Detection
A new analytical approach can detect trace levels of cannabis in breast milk
Joshua Crossney updates us about the events that are getting the medicinal cannabis industry talking.
The Pesticide Problem
To keep cannabis consumers safe, tests for pesticide residues must use multiple methods.
What’s in a Name?
As cannabis takes its rightful place as an important botanical medicine, it’s time to consign the term ‘marijuana’ to the history books.
Towards Mindful Consumption
By improving knowledge about cannabis, we can help consumers make the best decisions for them – and make the most of the benefits.
Looking to the Stars
An interview with Alisha Holloway, Director of Bioinformatics at Phylos Bioscience, Portland, Oregon and Assistant Adjunct Professor, Department of Epidemiology and ...
Breeding Better Buds
An Interview with Daniela Vergara, postdoctoral researcher at the University of Colorado, Founder and President of the Agricultural Genomics Foundation, and co-Founder ...
Into the Cannabinome
An interview with Kevin A Schug, Professor and Shimadzu Distinguished Professor of Analytical Chemistry at the University of Texas in Arlington, USA.
Cleaning Up Cannabis
Sitting Down With…Robert Martin, Chief Operating Officer of CW Analytical and Executive Director of the Association of Commercial Cannabis Laboratories (ACCL), ...
Cannabinoids: More Research, Please!
Four researchers in health, pharma and psychology describe how cannabinoids fit in with their work – and why further research is needed to help advance treatment. ...
THC versus AD
Tetrahydrocannabinol may be neuroprotective against early symptoms of Alzheimer’s disease
The Times They Are A-changin’
The Marijuana Policy Project is pushing for reform in cannabis legislation. Morgan Fox tells us more.
The Importance of Building Bridges
Pulling the medical cannabis and analytical science communities together has been challenging
Smoke and Mirrors – and Red Tape
Knowledge lags behind practice on medical marijuana. Cutting back on excessive bureaucracy for researchers is likely to help us all catch up.
Modernizing the Cannabis Industry
Genomics tools have the potential to transform Cannabis cultivation – but collaboration between science and industry is essential for success.